Fortrans sackets №4

Description

FORTRANS SACKETS COMPOSITION
active ingredients: 1 sachet contains polyethylene glycol 4000 64.00 g

sodium sulfate anhydrous 5.70 g

sodium bicarbonate 1.68 g

sodium chloride 1.46 g

potassium chloride 0.75 g

excipients: sodium saccharin.

DOSAGE FORM
Powder for oral solution.

BASIC PHYSICAL AND CHEMICAL PROPERTIES.
White powder that dissolves easily in water.

PHARMACOLOGICAL GROUP
Osmotic laxatives. ATX code A06A D65.

PHARMACOLOGICAL PROPERTIES

Pharmacological.

The volume of non-adsorbed fluid in the intestine is responsible for the laxative effect of the drug solution.

Fortrans sackets Pharmacokinetics.

The drug is not absorbed or metabolized. It is excreted from the body unchanged.

INDICATIONS
Colon cleansing to prepare patients for:

endoscopic or X-ray examination of the large intestine
surgical interventions on the large intestine.
Fortrans is indicated for use by adults.

CONTRAINDICATIONS
Hypersensitivity to the active or auxiliary substances of the drug.
Severe disorders of the general condition of the patient, for example, dehydration or severe heart failure.
Widespread carcinoma or any other disease of the colon accompanied by widespread damage to the intestinal mucosa.
Presence or risk of intestinal obstruction or gastrointestinal obstruction.
Perforation or threat of perforation of the gastrointestinal tract.
Abdominal pain of undetermined origin.
Disorders of stomach emptying (eg, gastroparesis).
Toxic colitis or toxic megacolon.

FEATURES OF APPLICATION

Elderly people with poor health are recommended to use the drug only under the supervision of a doctor.

This medicinal product contains polyethylene glycol (polyethylene glycol or PEG).

The drug should not cause electrolyte imbalance, given its isotonic composition, however, exceptional cases of water-electrolyte disturbances have been recorded in patients at risk. Patients with manifestations of dehydration or patients with electrolyte abnormalities should be eliminated before using this medicine for bowel cleansing. This drug should be used with caution in patients suffering from such disorders, as well as in patients who are simultaneously taking drugs that increase the risk of water and electrolyte disorders, including hyponatremia and hypokalemia, or may increase the risk of potential complications (for example, patients with impaired renal function , heart failure, or while being treated with diuretic drugs). In this case, patients require proper supervision.